目錄:MedChemExpress LLC>>生化試劑>> SDMA | MCE
CAS | 30344-00-4 | 純度 | ≥98.0% |
---|---|---|---|
分子量 | 202.25 | 分子式 | C?H??N?O? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 10 mg |
貨號 | HY-101410 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報,,我們不為任何個人用途提供產(chǎn)品和服務(wù)。
CAS No. : 30344-00-4
產(chǎn)品活性:SDMA (Symmetric dimethylarginine) is an endogenous inhibitor of nitric oxide (NO) synthase activity.
研究領(lǐng)域:Metabolic Enzyme/Protease
作用靶點:Endogenous Metabolite
結(jié)構(gòu)分類:酮,、醛,、酸
In Vitro: SDMA is the structural isomer of the cardiovascular risk marker asymmetric dimethylarginine, as an endogenous marker of renal function. SDMA does not directly inhibit NOS but is a competitor of arginine transport. SDMA is primarily eliminated by renal excretion and is a promising endogenous marker of glomerular filtration rate. SDMA inhibits dose dependently the NO synthesis in intact endothelial cells, whereas it has no effect on protein expression of NOS. SDMA is involved in the inflammatory process of chronic kidney disease, activating NF-κB and resulting in enhanced expression of IL-6 and TNF-α.
In Vivo: SDMA is highly stable in serum and plasma, and the assay demonstrates excellent analytical performance. In unaffected dogs, SDMA remains unchanged whereas in affected dogs, SDMA increases during disease progression, correlating strongly with an increase in sCr and decrease in GFR. Chronic SDMA infusion leads to a significant increase of SDMA levels in mice, but the GFR did not change at 4 weeks. No histological changes are observed, particularly no effect on fibrosis or endothelias nitric oxide synthase expression. There is neither an effect of SDMA on systolic blood pressure nor on ejection fraction.
相關(guān)產(chǎn)品:Natural Product Library Plus | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Metabolism/Protease Compound Library | Natural Product Library | Human Endogenous Metabolite Compound Library | Food-Sourced Compound Library | Human Metabolite Library | D-Valine-d8 | D-α-Hydroxyglutaric acid disodium | Nicotinamide N-oxide | Deoxycholic acid-d5 | Doxorubicin-13C,d3 (TFA) | Palitantin | Estradiol hemihydrate | Adrenaline sulfate | Oleic acid-13C | Dextranase | H2S Donor 5a | Methylmalonic acid | Glycine, N-(aminoiminomethyl)-N-methyl-13C | Dihydroxyacetone phosphate | Sphingomyelin | (-)-Jasmonoyl-L-isoleucine | Octanoic acid-d2 | Vardenafil-d5 | N-Acetyllactosamine | D-Arabitol-13C | Imidazole | L-Tartaric acid diammonium | i-Inositol | Tryptophol | L-Aspartic acid | Indolelactic acid | 6-Mercaptopurine-13C2,15N | D-Sorbitol-d8 | Octanoic acid-d3 | Dinoprost-d4
熱門產(chǎn)品線:重組蛋白 | 化合物庫 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物 | 寡核苷酸 | 抗體 | 點擊化學(xué)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫,我們致力于為*科研客戶提供前沿的高品質(zhì)小分子活性化合物,;
• 50,000 多種高選擇性抑制劑,、激動劑涉及各熱門信號通路及疾病領(lǐng);
• 產(chǎn)品種類涵蓋各種重組蛋白,,多肽,,常用試劑盒 ,更有 PROTAC,、ADC 等特色產(chǎn)品,,廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項目,;
• 提供虛擬篩選,,離子通道篩選,代謝組學(xué)分析檢測分析,,藥物篩選等專業(yè)技術(shù)服務(wù),;
• 設(shè)有專業(yè)的實驗中心和嚴格的質(zhì)控、驗證體系,;
• 提供 LC/MS,、NMR、HPLC,、手性分析、元素分析等各項質(zhì)檢報告,,確保產(chǎn)品的高純度,、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果,;
• 專業(yè)團隊跟蹤最新的制藥及生命科學(xué)研究進展,,為您提供*新的活性化合物;
• 與世界各大制藥公司及著名科研機構(gòu)建立了長期的合作,。
(空格分隔,最多3個,單個標(biāo)簽最多10個字符)